Barclays’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Buy |
231,104
+107,041
| +86% | +$1.5M | ﹤0.01% | 1913 |
|
|
2025
Q1 | $1.67M | Sell |
124,063
-33,797
| -21% | -$456K | ﹤0.01% | 2146 |
|
|
2024
Q4 | $3.03M | Buy |
157,860
+32,463
| +26% | +$622K | ﹤0.01% | 1946 |
|
|
2024
Q3 | $2.85M | Buy |
125,397
+66,550
| +113% | +$1.51M | ﹤0.01% | 1926 |
|
|
2024
Q2 | $765K | Sell |
58,847
-65,301
| -53% | -$849K | ﹤0.01% | 2272 |
|
|
2024
Q1 | $2.17M | Sell |
124,148
-95,445
| -43% | -$1.67M | ﹤0.01% | 1876 |
|
|
2023
Q4 | $4.78M | Buy |
219,593
+88,036
| +67% | +$1.92M | ﹤0.01% | 1521 |
|
|
2023
Q3 | $2.02M | Sell |
131,557
-125,979
| -49% | -$1.93M | ﹤0.01% | 1667 |
|
|
2023
Q2 | $6.13M | Buy |
257,536
+141,393
| +122% | +$3.36M | ﹤0.01% | 1123 |
|
|
2023
Q1 | $2.95M | Buy |
116,143
+16,823
| +17% | +$428K | ﹤0.01% | 1402 |
|
|
2022
Q4 | $2.9M | Sell |
99,320
-554,431
| -85% | -$16.2M | ﹤0.01% | 1417 |
|
|
2022
Q3 | $13.4M | Buy |
653,751
+635,456
| +3,473% | +$13M | 0.01% | 719 |
|
|
2022
Q2 | $212K | Buy |
18,295
+1,295
| +8% | +$15K | ﹤0.01% | 3090 |
|
|
2022
Q1 | $314K | Buy |
+17,000
| New | +$314K | ﹤0.01% | 3077 |
|
|
2019
Q3 | – | Sell |
-450
| Closed | -$1K | – | 4436 |
|
|
2019
Q2 | $1K | Sell |
450
-6,896
| -94% | -$15.3K | ﹤0.01% | 4180 |
|
|
2019
Q1 | $20K | Buy |
7,346
+7,334
| +61,117% | +$20K | ﹤0.01% | 3914 |
|
|
2018
Q4 | $0 | Sell |
12
-10,336
| -100% | – | ﹤0.01% | 4414 |
|
|
2018
Q3 | $57K | Buy |
10,348
+8,469
| +451% | +$46.7K | ﹤0.01% | 3697 |
|
|
2018
Q2 | $12K | Sell |
1,879
-3,912
| -68% | -$25K | ﹤0.01% | 3855 |
|
|
2018
Q1 | $41K | Buy |
5,791
+3,241
| +127% | +$22.9K | ﹤0.01% | 3583 |
|
|
2017
Q4 | $27K | Buy |
2,550
+2,258
| +773% | +$23.9K | ﹤0.01% | 3601 |
|
|
2017
Q3 | $3K | Sell |
292
-3,650
| -93% | -$37.5K | ﹤0.01% | 3817 |
|
|
2017
Q2 | $51K | Buy |
3,942
+1,922
| +95% | +$24.9K | ﹤0.01% | 3019 |
|
|
2017
Q1 | $25K | Buy |
+2,020
| New | +$25K | ﹤0.01% | 3311 |
|
|
2015
Q3 | – | Sell |
-63,000
| Closed | -$126K | – | 4129 |
|
|
2015
Q2 | $126K | Buy |
+63,000
| New | +$126K | ﹤0.01% | 2265 |
|